Insights

Gathering insights about BIVA…

Similar companies to BIVA

BIVA Tech Stack

BIVA uses 8 technology products and services including cdnjs, jQuery CDN, Cloudflare, and more. Explore BIVA's tech stack below.

cdnjs
Content Delivery Network
jQuery CDN
Content Delivery Network
Cloudflare
Content Management System
Font Awesome
Font Scripts
React
Javascript Frameworks
HSTS
Security
Google Tag Manager
Tag Management
Facebook
Widgets

Media & News

Abivax Establishes an At-the-Market (ATM) Program on Nasdaq
Abivax Establishes an At-the-Market (ATM) Program on Nasdaq PARIS, France, November 19, 2024 – 10:30PM CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq - ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the inflammatory response in patients with chronic inflammatory diseases, today announced the implementation of an At-The-Market program (“ATM Program”) allowing the Company to issue and sell, including with unsolicited investors who have expressed an interest, ordinary shares in the form of American Depositary Shares (“ADS”), each ADS representing one ordinary share, nominal value €0.01 per share, of the Company, with aggregate gross sales proceeds of up to $150,000,000 (subject to French regulatory limits and within the limits of the investors' requests expressed in the context of the program), from time to time, pursuant to the terms of an equity distribution agreement with Piper Sandler & Co. (“Piper Sandler”), acting as sales agent. The timing of any issuances in the form of ADSs will depend on a variety of factors.
Nov 19, 2024 | www.globenewswire.com
Abivax presents third quarter 2024 key financial information
Abivax presents third quarter 2024 key financial information PARIS, France, November 14, 2024, 10:00 p.m. CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the inflammatory response in patients with chronic inflammatory diseases, announces today its key financial information for the quarter ended September 30, 2024.
Nov 14, 2024 | www.globenewswire.com
Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax
Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax
Nov 13, 2024 | www.globenewswire.com
Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation
Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation
Oct 07, 2024 | www.globenewswire.com
Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn's Disease
Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn's Disease PARIS, France, October 3, 2024 – 10:00 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX; Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases, today announced the first patient was enrolled in its Phase 2b ENHANCE-CD (NCT06456593) trial evaluating obefazimod in patients with Crohn's disease (CD).
Oct 03, 2024 | www.globenewswire.com
Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients After 2-Years of Open-Label Maintenance
Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients After 2-Years of Open-Label Maintenance
Oct 03, 2024 | www.globenewswire.com
Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024
Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024 Professor Bruce E. Sands, MD to present oral presentation of Phase 2b, open-label, maintenance efficacy and safety data at weeks 48 and 96 among week 8 induction non-responders in obefazimod-treated patients with moderately to severely active ulcerative colitis (UC) Two moderated poster presentations highlighting corticosteroid-free efficacy and safety data of obefazimod at weeks 48 and 96 of an open-label maintenance trial, as well as the impact of obefazimod induction therapy on combined histologic and endoscopic outcomes at week 8 in patients with UC PARIS, France, September 26, 2024 – 08:30 a.m.
Sep 26, 2024 | www.globenewswire.com

BIVA's Email Address Formats

BIVA uses at least 1 format(s):

BIVA Email Formats	Example	Percentage
FLast@biva.mx	JDoe@biva.mx	48%
LFirst@biva.mx	DJohn@biva.mx	2%
FLast@biva.mx	JDoe@biva.mx	48%
LFirst@biva.mx	DJohn@biva.mx	2%

Frequently Asked Questions

Where is BIVA's headquarters located?

BIVA's main headquarters is located at Blvd. M. Ávila Camacho CDMX, CDMX 11000 MX. The company has employees across 6 continents, including North AmericaEuropeAsia.

What is BIVA's stock symbol?

BIVA is a publicly traded company; the company's stock symbol is ABVX.

What is BIVA's official website and social media links?

BIVA's official website is biva.mx and has social profiles on LinkedIn.

How much revenue does BIVA generate?

As of November 2024, BIVA's annual revenue reached $15M.

What is BIVA's NAICS code?

BIVA's NAICS code is 52 - Finance and Insurance.

How many employees does BIVA have currently?

As of November 2024, BIVA has approximately 113 employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief Of Staff: M. T.Chief Of Staff: M. T.Head Of Sustainability And Esg Listings: J. L. C. V.. Explore BIVA's employee directory with LeadIQ.

What industry does BIVA belong to?

BIVA operates in the Financial Services industry.

What technology does BIVA use?

BIVA's tech stack includes cdnjsjQuery CDNCloudflareFont AwesomeReactHSTSGoogle Tag ManagerFacebook.

What is BIVA's email format?

BIVA's email format typically follows the pattern of . Find more BIVA email formats with LeadIQ.

BIVA

Financial ServicesCDMX, Mexico51-200 Employees

BIVA tiene como propósito contribuir al crecimiento del mercado de valores a través de la innovación, el uso de la tecnología de punta y mayor accesibilidad.